HPCM
VYGR icon

Hunter Perkins Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Hunter Perkins Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73K Hold
20,965
– – 0.02% 148
2026
Q1 		$81K Hold
20,965
– – 0.02% 141
2025
Q4 		$82K Sell
20,965
-32,875
-61% -$145K 0.02% 114
2025
Q3 		$251K Sell
53,840
-6,500
-11% -$23.5K 0.06% 111
2025
Q2 		$188K Hold
60,340
– – 0.04% 107
2025
Q1 		$204K Sell
60,340
-2,700
-4% -$12.6K 0.05% 100
2024
Q4 		$357K Sell
63,040
-1,000
-2% -$6.45K 0.07% 95
2024
Q3 		$375K Buy
64,040
+2,025
+3% +$14.7K 0.08% 98
2024
Q2 		$491K Sell
62,015
-3,150
-5% -$26.4K 0.1% 94
2024
Q1 		$607K Buy
+65,165
New +$550K 0.12% 85

Other funds holding VYGR

PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Hunter Perkins Capital Management's VYGR Position: Q2 2026 in Review

Hunter Perkins Capital Management held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 20,965 shares worth $73K. The position accounts for 0.02% of the portfolio, ranked #148.

Hunter Perkins Capital Management first reported a position in VYGR in Q1 2024 and has held it in 10 quarters since. The position peaked at $607K in Q1 2024. 18 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Hunter Perkins Capital Management held 20,965 shares of Voyager Therapeutics worth $73K as of Q2 2026.
  • Hunter Perkins Capital Management left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up 0.02% of Hunter Perkins Capital Management's portfolio in Q2 2026, its #148 holding.
  • Hunter Perkins Capital Management first reported a position in Voyager Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Hunter Perkins Capital Management's Voyager Therapeutics position peaked at $607K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.